No standalone psychedelic bill receives a House committee markup before the 2026 session recess; movement is confined to California's therapeutic access framework.

The US Congress is overwhelmed with other urgent issues — disaster relief, foreign policy crises — and psychedelic legislation can't get enough attention to move forward at the federal level this year. California is the one place where real legal progress on supervised psychedelic therapy is actually happening.

The docket is saturated with wildfire/flood/Venezuela priorities. Federal psychedelic action can't get floor time this cycle. State is where I can deliver.